RE: Update on pII clinical study of MRx-4DP00041 Nov 2020 20:00
There was a shortage of candidates Wondergoal. Not expecting any news on COVID until the start of next year at the earliest IMO. Q4 has turned into as soon as reasonably possible. From the interim results,
"As the COVID-19 pandemic has evolved in the UK, case numbers and hospitalisations have fluctuated resulting in unpredictable recruitment rates across all clinical trials in the field, including but not limited to 4D pharma's Phase II trial in patients hospitalised with COVID-19. As previously reported, the Company initially expected results from this trial in Q4 2020, though this will be dependent on future dynamics and case numbers. The Company continues to evaluate strategic options to support enrolment, and looks forward to announcing data and findings from the study as soon as reasonably possible."